본문 바로가기
R&D
Rooted in distinctive platform technology based on strong medicinal chemistry expertise, LCB is a global biotechnology company dedicated to drug discovery and development

Core Technology

Ligachemisty

Novel drug discovery using "building blocks", namely, drug scaffold with drug-like properties
Successful advancement of drug development pipeline in clinical stage
  • Delpazolid (antibiotics for gram-positive pathogens and TB)
  • Nokxaban (anticoagulant)
  • ADCs (anticancer), particularly the linker platform
Accelerated drug discovery by rapid candidate drug identification
5 to 3 years

LCB's Approach